A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening Academic Article uri icon

Overview

MeSH Major

  • Kallikreins
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Use of the panel to determine referral to biopsy could substantially reduce the number of unnecessary prostate biopsies.

publication date

  • February 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3035761

Digital Object Identifier (DOI)

  • 10.1158/1055-9965.EPI-10-1003

PubMed ID

  • 21148123

Additional Document Info

start page

  • 255

end page

  • 61

volume

  • 20

number

  • 2